Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qol Holdings CoTSE:3034 -3.88%88 EV-to-EBIT is 6.11 as of Sep. 01, 2026, which is 23% below its 10-year median of 7.98. GuruFocus rates TSE:3034 with a GF Score™ of 88/100 and a GF Value™ of 円2,300.34 (Fairly Valued). The stock has 3 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Qol Holdings Co ranks better than 88.05% on this metric.
The historical rank and industry rank for Qol Holdings Co's EV-to-EBIT or its related term are showing as below:
TSE:3034'
s EV-to-EBIT Range Over the Past 10 Years
Min: 3.93 Med: 7.98 Max: 13.24
Current: 6.12
During the past 13 years, the highest EV-to-EBIT of Qol Holdings Co was 13.24. The lowest was 3.93. And the median was 7.98.
TSE:3034's EV-to-EBIT is ranked better than 88.05% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.67
vs TSE:3034: 6.12
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Qol Holdings Co's Enterprise Value for the quarter that ended in Mar. 2026 was 円88,512 Mil.
Qol Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円17,337 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co EV-to-EBIT Related Terms
Qol Holdings Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's EV-to-EBIT falls into.
Qol Holdings Co's current Enterprise Value is 円105,979 Mil.
Qol Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円17,337 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) has a EV-to-EBIT of 6.11 as of Sep. 01, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Qol Holdings Co and its competitors. This is 23% below median its historical median of 7.98. Over the past decade, Qol Holdings Co's EV-to-EBIT has ranged from 3.93 to 13.24. According to the industry distribution chart, Qol Holdings Co ranks #57 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 11.9%.
Is Qol Holdings Co's EV-to-EBIT too high?
Qol Holdings Co's current EV-to-EBIT of 6.11 is 23% below median its 10-year median of 7.98. Over the past 10 years, this metric has ranged from a low of 3.93 to a high of 13.24. The Healthcare Providers & Services industry median EV-to-EBIT is 15.67. Qol Holdings Co's value of 6.11 is 61% below this industry median. Based on the distribution chart, Qol Holdings Co ranks #57 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Qol Holdings Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #57 out of 477 companies for EV-to-EBIT. This places Qol Holdings Co in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.67. Qol Holdings Co's value of 6.11 is 61% below this benchmark. Historically, Qol Holdings Co's own EV-to-EBIT has ranged from 3.93 to 13.24 over the past decade. While the company's 10-year median is 7.98 vs. the industry median of 15.67, Qol Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.67, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qol Holdings Co's current EV-to-EBIT of 6.11 is 61% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current EV-to-EBIT is 6.11, which is 23% below median its own 10-year median of 7.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Fairly Valued. The stock's GF Value™ is 円2,300.34, compared to a current price of 円2,429.00 — trading 5.6% above its estimated fair value. The current EV-to-EBIT is 6.11, which is 23% below median its 10-year median of 7.98 and 61% below the Healthcare Providers & Services industry median of 15.67. Qol Holdings Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current EV-to-EBIT is 6.11 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be overvalued.
The current stock price of 円2,429.00 is trading 5.6% above its estimated GF Value™ of 円2,300.34.
GuruFocus considers Qol Holdings Co to be Fairly Valued.
Key valuation signals for TSE:3034:
EV-to-EBIT: 6.11 (23% below median its 10-year median of 7.98)
GF Value™: 円2,300.34 vs. price of 円2,429.00 (5.6% above fair value)
Industry Position: 61% below the Healthcare Providers & Services median (#57 of 477)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
88GF Score
Get the complete analysis for TSE:3034
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
